Browsing by Author "Marzinke, Mark A."
Now showing items 1-6 of 6
-
Characterization of Human Immunodefciency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083
Marzinke, Mark A. et al. | Date Issued: 2021 -
Development and validation of a liquid chromatographic-tandem mass spectrometric assay for the quantification of cabotegravir and rilpivirine from dried blood spots
Weld, Ethel D. et al. | Date Issued: 2023 -
Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083
Marzinke, Mark A. et al. | Date Issued: 2023 -
HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention
Eshleman, Susan H. et al. | Date Issued: 2022 -
A phase 2 randomized trial of a rifapentine plus moxifloxacin-based regimen for treatment of pulmonary tuberculosis
Conde, Marcus B. et al. | Date Issued: 2016 -
Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial
Landovitz, Raphael J. et al. | Date Issued: 2020